Navigation Links
MRIGlobal Engages Industry Expert in Expansion of Molecular Diagnostic Division

KANSAS CITY, Mo., Sept. 9, 2013 /PRNewswire-USNewswire/ -- MRIGlobal today announced that it is working with Mary E. Holland as part of its continuing expansion of its Molecular Diagnostics Division, which helps commercial diagnostics developers get their products to market faster.

Holland brings years of experience in creating and expanding market segments in Clinical Molecular Diagnostics, with a focus on the development and marketing of core product lines for clinical reference laboratories and diagnostic product manufacturers. She will work closely with Maureen Thornton, Head of Global Business Development for MRIGlobal Molecular Diagnostics, and Meeta Patnaik, M.D.

Holland has served in multiple leadership roles, playing a key role in solidifying brand and product awareness as well as driving profits for multiple companies that went public or to a merger/acquisition by Fortune 500 companies.

She most recently served as Vice President of Sales and Marketing with Madison, Wisconsin-based EraGen Biosciences, now part of Luminex; prior to that she played an integral role in launching Third Wave Technologies. As an entrepreneur, she co-founded Oncogenetics Inc., a comprehensive cancer diagnostic reference laboratory.

"Mary Holland brings diverse and highly relevant experience to the MRIGlobal Molecular Diagnostics Team," said Michael Cassler, Ph.D., Director of MRIGlobal Diagnostics.  "She will help increase our service offering to a broader customer base and further our continued expansion into the commercial diagnostics sector, a priority for our business.  We are both excited and fortunate to have someone of Mary's caliber working for us as a key member of our team." 

About MRIGlobal

MRIGlobal Molecular Diagnostics is a division of MRIGlobal, established in 1944 as Midwest Research Institute. MRIGlobal is based in Kansas City, Mo., operates in nine states and Washington, D.C. MRIGlobal employs more than 500 and manages 2,600-plus workers through management and operations programs with government clients.

MRIGlobal's Diagnostics Division provides assay development for menu expansion in in vitro and molecular diagnostics, validation and clinical testing, sample access and reference material, and platform engineering and integration. MRIGlobal operates a Clinical Laboratory Improvement Amendments (CLIA)-laboratory accredited by the College of American Pathologists. MRIGlobal is ISO 9001 certified and employs current Good Manufacturing Practices and Good Laboratory Practices, and maintains Biosafety Level 3 laboratories.

For more information, visit

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MRIGlobal, DHMRI Align in Strategic Collaboration
2. NineSigma Engages AtriCure in the Ohio Third Frontier Open Innovation Incentive Program
3. New Resource Provides Herb Industry With Sources of Quality Specifications
4. Garage Start-ups Now Possible in Life Sciences Industry
5. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
6. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
7. Free Job Training: 55 Grants Available to Retrain Workers for Biofuels Industry
8. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
9. Prolongs Large Scale Manufacturing of Sickle Cell Product to be Headed by Industry Veteran
10. Ohios Bioscience Industry Effort Paying Off With Increase in Graduates and Accolades for the State
11. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
Breaking Biology News(10 mins):